跳至主要内容
临床试验/NCT03350698
NCT03350698招募中4 期

Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination (Version IV Dated 24Oct2017)

Eastern Virginia Medical School2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年4月6日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
100
试验地点
2
主要终点
# of participants with elevated HPV antibody titers from baseline to 7 months

研究概览

简要总结

Currently there are no standards for healthcare worker vaccination with the HPV, Gardasil-9 vaccine. For health care workers, the CDC only recommends for vaccination against hepatitis B, influenza virus, Measles, Mumps and Rubella (MMR), Chickenpox (Varicella), Tetanus, Diptheria, and Pertussis (Tdap), and meninogococcal infections6

详细描述

Initial antibody titers will be measured immediately prior to initial vaccination (month 0). This will entail a blood-draw sample (less than 1 teaspoon) that will be sent to FOCUS labs for evaluation. This will be paid for by funding received from Merck.

The three-dose vaccination schedule will be followed with injections at month 0, 2, and 6. Gardasil 9 dosing will be per the recommended and approved labeled guidelines. Post-vaccination titers would be measured at month 7, which is in alignment with the methods of previous studies. This will entail a blood-draw sample (less than 1 teaspoon) that will be sent to FOCUS labs for evaluation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
27 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Actively practicing attending surgeon in the field of Otolaryngology, General Surgery, Urology, or Obstetrics-Gynecology employed by EVMS or credentialed by CHKD and/or SNGH.
  • Current residents of EVMS Otolaryngology, General Surgery, Urology, or Obstetrics-Gynecology programs

排除标准

  • • Age 26 or younger
  • Age over 69
  • Hypersensitivity to vaccine component
  • History of severe allergic or hypersensitivity reactions to yeast
  • History of previous HPV vaccination with 9 valent vaccine
  • Moderate or severe acute illness

结局指标

主要结局

# of participants with elevated HPV antibody titers from baseline to 7 months

时间窗: baseline and 7 months

baseline change at 7 months post vaccine series. The antibody titer laboratory test will be used to record the levels

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Craig Derkay M.D.

Professor

Eastern Virginia Medical School

研究点 (2)

Loading locations...

相似试验